Abstract
Although inflammatory complications are common in preterm infants, their effects on neonatal immune development remain poorly defined. We therefore investigated whether severe bronchopulmonary dysplasia (BPD) and systemic infection, two major complications of prematurity, produce distinct immune signatures and change immune composition over time. We performed longitudinal high-dimensional immune profiling of residual whole blood from 38 preterm infants sampled every two weeks, along with 10 term infants at birth. Preterm infants with severe BPD showed a progressive increase in Th17-polarized CD4<sup>+</sup> T cells, neutrophils, and Th17-related cytokines compared to age-matched infants with moderate BPD. In contrast, some preterm infants with systemic bacterial or viral infections mounted robust CD8<sup>+</sup>, CD4<sup>+</sup>, and γδ T cell responses, with oligoclonal expansion, terminal differentiation, and coordinated plasma cytokine shifts that persisted well beyond resolution of infection. These findings demonstrate that different preterm comorbidities imprint the neonatal immune system in divergent ways. Longitudinal immune profiling offers a powerful tool to uncover these trajectories and identify potential targets for intervention.
Introduction
Preterm birth is a massive physiological shock. Infants are thrust into the world before their immune systems are fully "programmed," exposing them to the sterile-but-stressful environment of the Neonatal Intensive Care Unit (NICU). While it is well-established that preterm infants are at high risk for inflammatory complications, a clear map of how their immune systems develop in real-time has remained elusive.
A major hurdle in neonatal research is "blood volume debt." It is clinically and ethically difficult to take large research samples from a 2-pound infant without causing anemia. Consequently, most historical studies have relied on umbilical cord blood, which captures only a single snapshot at birth. This leaves a "black box" regarding the critical weeks and months of development that follow.
Methodology: The "Scavenger" Pipeline
To overcome the limitations of blood volume, researchers developed a clever "scavenger" pipeline. They collected residual whole blood (~100-300µL) that remained in tubes after routine clinical Complete Blood Counts (CBCs) were performed. By sampling these residues every two weeks, the team could track immune trajectories without additional needle sticks for the infants.
To analyze these tiny volumes, the study employed two high-dimensional "omics" platforms:
- CyTOF (Mass Cytometry): Used metal-tagged antibodies to identify 15 major immune cell populations and 33 sub-populations.
- Olink Proteomics: A proximity extension assay used to measure 88 different immune-related proteins in the plasma.
- TCR Sequencing: T-cell receptor sequencing was performed to determine if immune responses were polyclonal (broad and non-specific) or oligoclonal (targeted and antigen-driven).
The study followed a longitudinal cohort of 38 preterm infants (born between 23 and 32 weeks of gestation) and 10 term infants sampled at birth as a healthy baseline.
Key Insights: BPD and the Th17 Axis
The study demonstrated that Bronchopulmonary Dysplasia (BPD) is not merely a result of general inflammation but is characterized by a specific immune signature. Infants with severe (Grade 3) BPD showed a progressive increase in Th17-polarized CD4+ T cells and neutrophils.
Crucially, some of these markers—including CD161+ CD4+ T cells and cytokines like IL-17C and CCL20—were elevated early in life. This suggests that the immune trajectory for chronic lung disease might be set shortly after birth, potentially offering a window for early intervention via the IL-17 axis.
Adult-Like Responses to Infection
One of the most surprising findings challenged the notion that the neonatal immune system is inherently "weak" or passive. In response to systemic bacterial or viral infections (such as sepsis or CMV), some preterm infants mounted robust, adult-like immune responses.
In these cases, the naive CD8+ T cell pool—which usually accounts for over 95% of the total pool in neonates—plummeted to below 85% as cells shifted toward effector memory phenotypes. These reactions were accompanied by a massive surge in Type 1 cytokines, including IFN-γ and CXCL9. Furthermore, TCR sequencing revealed robust oligoclonal expansion, meaning specific T cell clones multiplied to fight the infection and remained in the system for weeks after the clinical resolution of the illness.
Conclusion and Future Directions
This research proves that clinical waste can be a goldmine for high-dimensional data, enabling longitudinal studies in fragile populations that were previously impossible. The findings demonstrate that the preterm immune system is highly reactive and that different comorbidities leave distinct, long-lasting "imprints" on immune development.
While the study provides a high-resolution map, limitations remain. The sample size for rare events like Necrotizing Enterocolitis (NEC) was too small for definitive conclusions, and the study did not account for the microbiome or maternal factors. Future work is needed to determine if these early-life immune imprints lead to long-term health issues such as asthma or autoimmunity, and whether targeting specific pathways like the Th17 axis could mitigate the severity of BPD.
Summary updated